Latest Regulatory Approvals News

Cobram Estate Olives has secured US Department of Justice approval for its acquisition of California Olive Ranch, paving the way for completion by late March 2026.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

Javelin Minerals has secured a major new gold exploration package in Western Australia’s Central Yilgarn region, setting the stage for an aggressive exploration campaign near established projects.

Aguia Resources has secured key mining concessions in Brazil, setting the stage for operational licensing and commissioning of its Tres Estradas phosphate mine by April 2026.

Alchemy Resources has agreed to sell its Karonie and Lake Rebecca gold projects to Forrestania Resources for $5 million in shares, while retaining a 1% royalty. This deal marks a strategic refocus on Alchemy’s promising New South Wales assets.

Sky Metals reports significant new high-grade tin-tungsten-silver drilling results at its Tallebung Tin Project, confirming southern extensions and initiating the NSW State Significant Development approval process.

Patrys has initiated manufacturing and regulatory steps for RLS-2201, its injectable Quetiapine formulation targeting delirium, aiming for Phase 0 trials in the second half of 2026.

NuEnergy Gas Limited has completed four wells under its Tanjung Enim Early Gas Sales Initiative, secured a binding gas sales agreement, and raised $3.5 million to advance its Indonesian coal bed methane projects.

Elanor Investors Group reported a $57 million statutory loss for FY25 but is progressing a $125 million recapitalisation with Rockworth Capital Partners to stabilise its balance sheet amid ongoing financial challenges.

Winton Land Limited has secured conditional approval under the Fast-track Approvals Act 2024 for its Sunfield masterplanned community, paving the way for thousands of homes and extensive commercial precincts.

Imugene Limited reports striking early results from its Phase 1b azer-cel trial, achieving a 100% overall response rate in chronic lymphocytic leukemia and 80% in marginal zone lymphoma, while broadening its study to include a BTK inhibitor combination.

QPM Energy Limited has announced a substantial upgrade to its Moranbah Gas Project reserves and resources, now certified at over 1,000 petajoules, positioning the company as a key player in Queensland’s evolving gas and electricity markets.